Giannitsi Sofia, Bougiakli Maria, Bechlioulis Aris, Naka Katerina
Michaelidion Cardiac Center, University of Ioannina, Greece.
2nd Department of Cardiology, University of Ioannina, Greece.
JRSM Cardiovasc Dis. 2019 Apr 11;8:2048004019843047. doi: 10.1177/2048004019843047. eCollection 2019 Jan-Dec.
Heart failure affects 1-2% of the population worldwide, and it is characterized by episodes of decompensation often requiring hospitalization. Although targeted treatment has reduced the prevalence of rehospitalizations to 30-50%, mortality rates remain high. A complex blend of structural and functional alterations accounts for the genesis and progression of heart failure, but the exact underlying pathophysiology remains poorly understood. The aim of this review is to summarize endothelial dysfunction and its role in the pathogenesis and progression of heart failure. Moreover, it sums up all the appropriate methods of assessing endothelial dysfunction emphasizing on flow-mediated dilation and introduces endothelium as a potential target for new therapeutic development and research in the wide spectrum of the syndrome called heart failure.
心力衰竭影响着全球1%至2%的人口,其特征是常需住院治疗的失代偿发作。尽管靶向治疗已将再住院率降低至30%至50%,但死亡率仍然很高。结构和功能改变的复杂组合导致了心力衰竭的发生和进展,但其确切的潜在病理生理学仍知之甚少。本综述的目的是总结内皮功能障碍及其在心力衰竭发病机制和进展中的作用。此外,它总结了评估内皮功能障碍的所有适当方法,重点是血流介导的扩张,并将内皮作为心力衰竭这一广泛综合征新治疗开发和研究的潜在靶点进行了介绍。